France 1,4 Butanediol Market Size & Outlook, 2025-2030
France 1,4 Butanediol Market, 2018-2030 (US$M)
France 1,4 butanediol market highlights
- The France 1,4 butanediol market generated a revenue of USD 85.8 million in 2024 and is expected to reach USD 152.2 million by 2030.
- The France market is expected to grow at a CAGR of 8.4% from 2025 to 2030.
- In terms of segment, tetrahydrofuran (thf) was the largest revenue generating application in 2024.
- Tetrahydrofuran (THF) is the most lucrative application segment registering the fastest growth during the forecast period.
1,4 butanediol market data book summary
| Market revenue in 2024 | USD 85.8 million |
| Market revenue in 2030 | USD 152.2 million |
| Growth rate | 8.4% (CAGR from 2024 to 2030) |
| Largest segment | Tetrahydrofuran (thf) |
| Fastest growing segment | Tetrahydrofuran (THF) |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Tetrahydrofuran (THF), Polybutylene Terephthalate (PBT), Gamma-Butyrolactone (GBL), Polyurethane (PU) |
| Key market players worldwide | Basf SE, Ashland Inc, DCC PLC, Mitsubishi Chemical Group Corp, Evonik Industries AG, LyondellBasell Industries NV Class A, China Petroleum & Chemical Corp Class H, Sipchem, Genomatica |
Other key industry trends
- In terms of revenue, France accounted for 1.1% of the global 1,4 butanediol market in 2024.
- Country-wise, China is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany 1,4 butanediol market is projected to lead the regional market in terms of revenue in 2030.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 436.9 million by 2030.
This country is anticipated to exhibit lucrative growth owing to an increasing number of clinical trials in the region, which requires highly equipped medical infrastructure. For instance, as of April 2023, over 5179 medical device clinical trials were registered in the country.
Outsourcing medical devices leads to the optimization of resources & costs, facilitating a greater focus on innovation capabilities. Moreover, smaller companies in this country are increasingly entering the market by offering medical devices at low prices and shifting the focus of large healthcare industry players toward innovation.
No credit card required*
Publish Date: Dec 02, 2024
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
1,4 Butanediol Market Scope
1,4 Butanediol Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Basf SE | View profile | 111,855 | Carl-Bosch-Strasse 38, Ludwigshafen am Rhein, Germany, 67056 | www.basf.com |
| Evonik Industries AG | View profile | 33,409 | Rellinghauser Strasse 1-11, Essen, NW, Germany, 45128 | www.evonik.com |
| LyondellBasell Industries NV Class A | View profile | 20,000 | One Vine Street, 4th Floor, London, United Kingdom, W1J0AH | www.lyondellbasell.com |
| Ashland Inc | View profile | 3,800 | 8145 Blazer Drive, Wilmington, DE, United States, 19808 | www.ashland.com |
| Mitsubishi Chemical Group Corp | View profile | 74,632 | 1-1 Marunouchi 1-chome, Chiyoda-ku, Tokyo, Japan, 100-8251 | www.mcgc.com |
| DCC PLC | View profile | 16,600 | Leopardstown Road, DCC House, Foxrock, Dublin, Ireland, D18 PK00 | www.dcc.ie |
| China Petroleum & Chemical Corp Class H | View profile | 368,450 | No. 22 Chaoyangmen North Street, Chaoyang District, Beijing, China, People's Republic of, 100728 | www.sinopec.com |
| Genomatica | View profile | 101-250 | San Diego, California, United States, North America | www.genomatica.com |
| Sipchem | View profile | 5001-10000 | Al Khobar, Ash Sharqiyah, Saudi Arabia, Asia | www.sipchem.com |
France 1,4 Butanediol Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to 1,4 Butanediol Market Outlook will help companies and investors design strategic landscapes.
Tetrahydrofuran (Thf) was the largest segment with a revenue share of 50.47% in 2024.
Horizon Databook has segmented the France 1,4 butanediol market based on tetrahydrofuran (thf), polybutylene terephthalate (pbt), gamma-butyrolactone (gbl), polyurethane (pu) covering the revenue growth of each sub-segment from 2018 to 2030.
This country is anticipated to exhibit lucrative growth owing to an increasing number of clinical trials in the region, which requires highly equipped medical infrastructure. For instance, as of April 2023, over 5179 medical device clinical trials were registered in the country.
Outsourcing medical devices leads to the optimization of resources & costs, facilitating a greater focus on innovation capabilities. Moreover, smaller companies in this country are increasingly entering the market by offering medical devices at low prices and shifting the focus of large healthcare industry players toward innovation.
- France 1,4 Butanediol Market Application Outlook (Revenue, USD Million , 2018-2030)
- Tetrahydrofuran (THF)
- Polybutylene Terephthalate (PBT)
- Gamma-Butyrolactone (GBL)
- Polyurethane (PU)
- Others
Reasons to subscribe to 1,4 Butanediol Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of 1,4 Butanediol Market Outlook databook
- Our clientele includes a mix of 1,4 Butanediol Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France 1,4 Butanediol Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into France 1,4 Butanediol Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
France 1,4 Butanediol Market, 2018-2030 (US$M)
France 1,4 butanediol market statistics, by application, 2018-2030 (US$M)
